Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Stavudine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1193021A discloses a scalable method for synthesizing stavudine (d4T) from 5-methyluridine using zinc reductive elimination, offering significant cost reduction and high purity for pharmaceutical manufacturing.